LIVE FROM THE DATABASETRANSACTIONS 723,028COMPANIES 6,565LATEST TRADE Oct 26UPDATED Oct 27, 06:30 PM

Reporting ownerCIK 0001606653

Richard T. Kenney

13 transactions in one company, from June 30, 2025 to December 2, 2025.

By company

Where this insider traded.

Company	Ticker	Trades	Bought	Sold
Sonnet BioTherapeutics Holdings, Inc.	SONN	13	—	—

13 in total, newest filings first.

Company	Ticker	Insider	Date	Code	Shares	Price	Value	Held after
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMODERIV	Dec 2	MOption exercise	200	—	—	0derivatives
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMODERIV	Dec 2	DReturned to issuer	320,000	—	—	0derivatives
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMODERIV	Dec 2	MOption exercise	86,505	—	—	0derivatives
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMO	Dec 2	DReturned to issuer	163,760	—	—	0
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMO	Dec 2	MOption exercise	163,760	—	—	163,760
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMO	Dec 2	DReturned to issuer	69,614	—	—	0
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMO	Dec 2	FTax withholding	16,891	—	—	69,614
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMO	Dec 2	MOption exercise	86,505	—	—	86,505
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMO	Dec 2	DReturned to issuer	9,374	—	—	0
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMODERIV	Jul 14	AAward	200	—	—	200derivatives
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMODERIV	Jul 14	AAward	320,000	—	—	320,000derivatives
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMODERIV	Jun 30	AAward	86,505	—	—	86,505derivatives
Sonnet BioTherapeutics Holdings, Inc.	SONN	Richard T. KenneyCMO	Jul 11	AAward	8,000	—	—	9,374